Screener
ImmunityBio, Inc. IBRX Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Related-party convertible note payable, at fair value (Note 14) | 678,386 | 477,093 |
| Revenue interest liability (Note 13) | 404,299 | 324,615 |
| Operating lease liabilities, less current portion | 20,062 | 19,732 |
| Operating lease liabilities, less current portion – related parties | 13,085 | 13,715 |
| Derivative liabilities (Note 13) | 23,314 | 19,722 |
| Warrant liabilities (Note 16) | 308,193 | 84,417 |
| Other liabilities | 472 | 424 |
| Total liabilities | 1,515,763 | 1,001,472 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s other non-current liabilities?
- ImmunityBio, Inc. (IBRX) reported other non-current liabilities of $472K in Q1 2026.
- How has ImmunityBio, Inc.'s other non-current liabilities changed year-over-year?
- ImmunityBio, Inc.'s other non-current liabilities increased by 27.6% year-over-year, from $370K to $472K.
- What is the long-term trend for ImmunityBio, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s other non-current liabilities has grown at a -16.3% compound annual growth rate (CAGR), from $1.04M to $424K.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about ImmunityBio, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude